Home /Research /aCD47-docetaxel immuno-chemotherapy: A two-pronged attack against 'cold' glioblastoma.
OTHER

aCD47-docetaxel immuno-chemotherapy: A two-pronged attack against 'cold' glioblastoma.

Palange AL, Guerriero I, Spanò R, Susana A, López-Estévez AM, Furnari AG, Pesce C, Albanesi E, Lugli E, Di Mascolo D, Decuzzi P

Year
2026
Journal
Journal of controlled release : official journal of the Controlled Release Society

Keywords

immunotherapychemotherapyglioblastomacold tumoraCD47

Related papers

Browse all OTHER papers